SENESTECH INC

Glenbrook’s 30% stake in SenesTech boosts investor confidence, driving a 14% price jump and fueling prospects for a pest‑control biotech’s growth.

SenesTech CEO’s latest 2,000‑share purchase at $0.64 signals confidence amid a steep decline, hinting at possible undervaluation and future rebound.

SenesTech CEO’s latest insider purchases hint at confidence in its pest‑control tech, sparking curiosity amid steep declines and low market cap.